Literature DB >> 34298583

Serum albumin and risks of hospitalization and death: Findings from the Atherosclerosis Risk in Communities study.

Colleen M Shannon1, Shoshana H Ballew2,3, Natalie Daya2,3, Linda Zhou2,3, Alex R Chang4, Yingying Sang2,3, Josef Coresh2,3, Elizabeth Selvin2,3, Morgan E Grams2,3,5.   

Abstract

OBJECTIVES: To determine whether lower serum albumin in community-dwelling, older adults is associated with increased risk of hospitalization and death independent of pre-existing disease.
DESIGN: Prospective cohort study of participants in the fifth visit of the Atherosclerosis Risk in Communities (ARIC) study. Baseline data were collected from 2011 to 2013. Follow-up was available to December 31, 2017. Replication was performed in Geisinger, a health system in rural Pennsylvania.
SETTING: For ARIC, four US communities: Washington County, Maryland; Forsyth County, North Carolina; Jackson, Mississippi; and suburbs of Minneapolis, Minnesota. PARTICIPANTS: A total of 4947 community-dwelling men and women aged 66 to 90 years. EXPOSURE: Serum albumin. MAIN OUTCOMES: Incident all-cause hospitalization and death.
RESULTS: Among the 4947 participants, mean age was 75.5 years (SD: 5.12) and mean baseline serum albumin concentration was 4.05 g/dL (SD: 0.30). Over a median follow-up period of 4.42 years (interquartile interval: 4.16-5.05), 553 participants (11.2%) died and 2457 participants (49.7%) were hospitalized at least once. The total number of hospitalizations was 5725. In analyses adjusted for demographics and numerous clinical characteristics, including tobacco use, obesity, frailty, cardiovascular disease, kidney disease, diabetes C-reactive protein (CRP), cognitive status, alcohol use, medication use, respiratory disease, and systolic blood pressure, 1 g/dL lower baseline serum albumin concentration was associated with higher risk of both hospitalization (incidence rate ratio [IRR]: 1.58; 95% confidence interval [CI]: 1.36-1.82; p < 0.001) and death (hazard ratio [HR]: 1.67; 95% CI: 1.24-2.24; p < 0.001). Associations were weaker with older age but not different by frailty status or level of high-sensitivity CRP. Associations between serum albumin, hospitalizations, and death were also similar in a real-world cohort of primary care patients.
CONCLUSIONS: Lower baseline serum albumin was significantly associated with increased risk of both all-cause hospitalization and death, independent of pre-existing disease. Older adults with low serum albumin should be considered a high-risk population and targeted for interventions to reduce the risk of adverse outcomes.
© 2021 The Authors. Journal of the American Geriatrics Society published by Wiley Periodicals LLC on behalf of The American Geriatrics Society.

Entities:  

Keywords:  bromocresol purple; death; frailty; hospitalization; serum albumin

Mesh:

Substances:

Year:  2021        PMID: 34298583      PMCID: PMC8582595          DOI: 10.1111/jgs.17313

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   7.538


  31 in total

1.  Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study.

Authors:  Luc Djoussé; Kenneth J Rothman; L Adrienne Cupples; Daniel Levy; R Curtis Ellison
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

2.  The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis.

Authors:  W F Owen; N L Lew; Y Liu; E G Lowrie; J M Lazarus
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

3.  The prognostic value of serum albumin in healthy older persons with low and high serum interleukin-6 (IL-6) levels.

Authors:  D B Reuben; L Ferrucci; R Wallace; R P Tracy; M C Corti; H Heimovitz; T B Harris
Journal:  J Am Geriatr Soc       Date:  2000-11       Impact factor: 5.562

4.  Serum albumin, coronary heart disease risk, and mortality in an elderly cohort.

Authors:  M P Weijenberg; E J Feskens; J H Souverijn; D Kromhout
Journal:  Epidemiology       Date:  1997-01       Impact factor: 4.822

5.  Death risk predictors among peritoneal dialysis and hemodialysis patients: a preliminary comparison.

Authors:  E G Lowrie; W H Huang; N L Lew
Journal:  Am J Kidney Dis       Date:  1995-07       Impact factor: 8.860

6.  Albumin analysis in serum of haemodialysis patients: discrepancies between bromocresol purple, bromocresol green and electroimmunoassay.

Authors:  F E Wells; G M Addison; R J Postlethwaite
Journal:  Ann Clin Biochem       Date:  1985-05       Impact factor: 2.057

7.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

8.  Survival advantage of cohort participation attenuates over time: results from three long-standing community-based studies.

Authors:  Zihe Zheng; Casey M Rebholz; Kunihiro Matsushita; Judith Hoffman-Bolton; Michael J Blaha; Elizabeth Selvin; Lisa Wruck; A Richey Sharrett; Josef Coresh
Journal:  Ann Epidemiol       Date:  2020-04-03       Impact factor: 3.797

9.  Overestimation of Albumin Measured by Bromocresol Green vs Bromocresol Purple Method: Influence of Acute-Phase Globulins.

Authors:  Vanessa Garcia Moreira; Nana Beridze Vaktangova; Maria Dolores Martinez Gago; Belen Laborda Gonzalez; Sara Garcia Alonso; Eloy Fernandez Rodriguez
Journal:  Lab Med       Date:  2018-10-11

Review 10.  Critical appraisal of the role of serum albumin in cardiovascular disease.

Authors:  Shih-Chieh Chien; Chun-Yen Chen; Chao-Feng Lin; Hung-I Yeh
Journal:  Biomark Res       Date:  2017-11-10
View more
  1 in total

1.  Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease.

Authors:  Francis Verbeke; Raymond Vanholder; Wim Van Biesen; Griet Glorieux
Journal:  J Pers Med       Date:  2022-07-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.